CEO of Maravai LifeSciences. "We plan to further evolve and enhance Molecular Assemblies’ workflows to push the limits of oligo length and purity, and to lower costs by vertically integrating ...

Trey Martin, CEO of Maravai LifeSciences, expressed confidence in the potential advancements the acquisition could bring, stating their intention to evolve Molecular Assemblies' workflows.

Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property ...

CEO of Maravai LifeSciences. "We plan to further evolve and enhance Molecular Assemblies’ workflows to push the limits of oligo length and purity, and to lower costs by vertically integrating NTPs and ...